These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26238446)

  • 1. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.
    Martínez-Martínez E; Calvier L; Fernández-Celis A; Rousseau E; Jurado-López R; Rossoni LV; Jaisser F; Zannad F; Rossignol P; Cachofeiro V; López-Andrés N
    Hypertension; 2015 Oct; 66(4):767-75. PubMed ID: 26238446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.
    Calvier L; Martinez-Martinez E; Miana M; Cachofeiro V; Rousseau E; Sádaba JR; Zannad F; Rossignol P; López-Andrés N
    JACC Heart Fail; 2015 Jan; 3(1):59-67. PubMed ID: 25458174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 mediates aldosterone-induced vascular fibrosis.
    Calvier L; Miana M; Reboul P; Cachofeiro V; Martinez-Martinez E; de Boer RA; Poirier F; Lacolley P; Zannad F; Rossignol P; López-Andrés N
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):67-75. PubMed ID: 23117656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
    López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice.
    Vergaro G; Prud'homme M; Fazal L; Merval R; Passino C; Emdin M; Samuel JL; Cohen Solal A; Delcayre C
    Hypertension; 2016 Mar; 67(3):606-12. PubMed ID: 26781273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.
    Martínez-Martínez E; Ibarrola J; Fernández-Celis A; Calvier L; Leroy C; Cachofeiro V; Rossignol P; López-Andrés N
    J Hypertens; 2018 Feb; 36(2):368-376. PubMed ID: 28858976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.
    Martínez-Martínez E; López-Ándres N; Jurado-López R; Rousseau E; Bartolomé MV; Fernández-Celis A; Rossignol P; Islas F; Antequera A; Prieto S; Luaces M; Cachofeiro V
    Hypertension; 2015 Nov; 66(5):961-9. PubMed ID: 26351031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage.
    Martinez-Martinez E; Ibarrola J; Calvier L; Fernandez-Celis A; Leroy C; Cachofeiro V; Rossignol P; Lopez-Andres N
    PLoS One; 2016; 11(11):e0166272. PubMed ID: 27829066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.
    Martínez-Martínez E; Brugnolaro C; Ibarrola J; Ravassa S; Buonafine M; López B; Fernández-Celis A; Querejeta R; Santamaria E; Fernández-Irigoyen J; Rábago G; Moreno MU; Jaisser F; Díez J; González A; López-Andrés N
    Hypertension; 2019 Mar; 73(3):602-611. PubMed ID: 30612490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis.
    Arrieta V; Martinez-Martinez E; Ibarrola J; Alvarez V; Sádaba R; Garcia-Peña A; Fernández-Celis A; Cachofeiro V; Rossignol P; López-Andrés N
    Clin Sci (Lond); 2017 May; 131(10):935-949. PubMed ID: 28360193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts.
    Ibarrola J; Sádaba R; Garcia-Peña A; Arrieta V; Martinez-Martinez E; Alvarez V; Fernández-Celis A; Gainza A; Santamaría E; Fernández-Irigoyen J; Cachofeiro V; Fay R; Rossignol P; López-Andrés N
    Int J Cardiol; 2018 May; 258():217-223. PubMed ID: 29544935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model.
    Ibarrola J; Martínez-Martínez E; Sádaba JR; Arrieta V; García-Peña A; Álvarez V; Fernández-Celis A; Gainza A; Rossignol P; Cachofeiro Ramos V; López-Andrés N
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage.
    Ibarrola J; Arrieta V; Sádaba R; Martinez-Martinez E; Garcia-Peña A; Alvarez V; Fernández-Celis A; Gainza A; Santamaría E; Fernández-Irigoyen J; Cachofeiro V; Zalba G; Fay R; Rossignol P; López-Andrés N
    Clin Sci (Lond); 2018 Jul; 132(13):1471-1485. PubMed ID: 29674526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Gelatinase-Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids.
    Tarjus A; Martínez-Martínez E; Amador C; Latouche C; El Moghrabi S; Berger T; Mak TW; Fay R; Farman N; Rossignol P; Zannad F; López-Andrés N; Jaisser F
    Hypertension; 2015 Jul; 66(1):158-66. PubMed ID: 25987661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy.
    Souza BSF; Silva DN; Carvalho RH; Sampaio GLA; Paredes BD; Aragão França L; Azevedo CM; Vasconcelos JF; Meira CS; Neto PC; Macambira SG; da Silva KN; Allahdadi KJ; Tavora F; de Souza Neto JD; Dos Santos RR; Soares MBP
    Am J Pathol; 2017 May; 187(5):1134-1146. PubMed ID: 28322201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.